Item | subgroup | n | Before treatment | After treatment | t | P |
Hb (g/L) |
| 61 | 96.62 ± 25.24 | 98.67 ± 21.59 | 0.8482 | >0.05 |
anemia | 42 | 84.57 ± 27.13 | 89.74 ± 25.26 | 1.9832 | <0.05 | |
Non-anaemia | 19 | 123.26 ± 31.12 | 118.37 ± 21.19 | 1.5866 | >0.05 | |
BMP6 (mg/ml) |
| 61 | 162.49 ± 86.35 | 158.61 ± 81.01 | 0.3424 | >0.05 |
anemia | 42 | 173.70 ± 82.33 | 168.66 ± 83.08 | 0.9647 | >0.05 | |
Non-anaemia | 19 | 137.72 ± 66.23 | 136.39 ± 71.25 | 0.0158 | >0.05 | |
Hepcidin (mg/L) |
| 61 | 1.02 ± 3.83 | 0.82 ± 0.24 | 2.5726 | <0.05 |
anemia | 42 | 1.05 ± 3.96 | 0.74 ± 0.19 | 2.9865 | <0.01 | |
Non-anaemia | 19 | 0.94 ± 3.22 | 0.96 ± 0.31 | 0.3514 | >0.05 | |
IL-6 (mg/ml) |
| 61 | 38.22 ± 31.23 | 24.88 ± 12.58 | 2.9650 | <0.01 |
anemia | 42 | 43.96 ± 33.42 | 26.60 ± 23.36 | 2.6715 | <0.01 | |
Non-anaemia | 19 | 33.42 ± 23.17 | 17.88 ± 13.18 | 3.1688 | <0.01 |